1998: The future begins… Ribavirin and interferon
- Methodologically sound; good randomization; equal treatment of groups outside of intervention.
- Adequate blindedness at all points.
- ITT analysis makes larger number of drop-outs in treatment group unlikely to have affected outcomes/results.
- ? RNA levels more clinically applicable endpoint.
- ? Supported by grant from Schering-Plough.